UPL Ltd
NSE:UPL
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
UPL Ltd
Operating Income
UPL Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
UPL Ltd
NSE:UPL
|
Operating Income
â‚ą27.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Operating Income
â‚ą3.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
219%
|
CAGR 10-Years
N/A
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Operating Income
â‚ą9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Sumitomo Chemical India Ltd
NSE:SUMICHEM
|
Operating Income
â‚ą4.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
PI Industries Ltd
NSE:PIIND
|
Operating Income
â‚ą17.2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Operating Income
â‚ą21.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
See Also
What is UPL Ltd's Operating Income?
Operating Income
27.5B
INR
Based on the financial report for Mar 31, 2024, UPL Ltd's Operating Income amounts to 27.5B INR.
What is UPL Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
6%
Over the last year, the Operating Income growth was -68%. The average annual Operating Income growth rates for UPL Ltd have been -24% over the past three years , -3% over the past five years , and 6% over the past ten years .